Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about VGLUT1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
The SLC17A7 (VGLUT1) gene encodes vesicular glutamate transporter 1, essential for excitatory neurotransmission in the cerebral cortex and hippocampus. This page covers its role in synaptic function, expression patterns, and implications for neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and epilepsy.
| Gene Symbol | VGLUT1 |
| Aliases | Vesicular Glutamate Transporter 1 |
| Chromosome | 19q13.33 |
| Primary Expression | glutamatergic (excitatory) neurons |
| Molecular Weight | 62 kDa |
| Amino Acids | 560 aa |
| Exons | 12 |
| Pathways | Amyloid, Apoptosis |
| Ensembl ID | ENSG00000177656 |
| GeneCards | VGLUT1 |
| Human Protein Atlas | VGLUT1 |
| Associated Diseases | ISCHEMIA, epilepsy, neurodegeneration |
| Interactions | TAU, APOE, APOE4, VEGF, GFAP, SLC17A6 |
| KG Connections | 197 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
VGLUT1["<b>VGLUT1</b>"]
Ms{"Ms"}
VGLUT1 -->|"activates"| Ms
LAMP1["LAMP1"]
VGLUT1 -->|"associated with"| LAMP1
Apoptosis(["Apoptosis"])
VGLUT1 -->|"activates"| Apoptosis
Phagocytosis(["Phagocytosis"])
VGLUT1 -->|"activates"| Phagocytosis
neurodegeneration["neurodegeneration"]
VGLUT1 -->|"implicated in"| neurodegeneration
style VGLUT1 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| SLC17A7 | encoded_by | gene | 0.99 |
| SYNAPTIC_VESICLE | localized_to | structure | 0.95 |
| V-ATPASE | depends_on | protein | 0.85 |
| TRORILUZOLE | pharmacological_target | drug | 0.70 |
| Ms | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Alzheimer | biomarker_for | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Epilepsy | inhibits | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Diabetes | inhibits | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Epilepsy | expressed_in | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Autoimmune | regulates | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| LAMP1 | associated_with | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| APOE4 | activates | gene | 0.60 |
| VEGF | activates | gene | 0.60 |
| GFAP | activates | gene | 0.60 |
| VGLUT2 | associated_with | gene | 0.60 |
| APP | regulates | gene | 0.60 |
| MAPT | regulates | gene | 0.60 |
| BACE1 | regulates | gene | 0.60 |
| VGLUT2 | expressed_in | gene | 0.60 |
| SLC17A6 | activates | gene | 0.60 |
| Synaptic Vesicle | activates | pathway | 0.60 |
| Synaptic Vesicle | expressed_in | pathway | 0.60 |
| Insulin Receptor | inhibits | protein | 0.60 |
| KDM6B | activates | gene | 0.60 |
| Nmda Receptor | transports | protein | 0.60 |
| epilepsy | activates | disease | 0.60 |
| neurodegeneration | activates | disease | 0.60 |
| epilepsy | associated_with | disease | 0.60 |
| neurodegeneration | associated_with | disease | 0.60 |
| VGLUT2 | regulates | gene | 0.60 |
| Apoptosis | activates | pathway | 0.60 |
| Phagocytosis | activates | pathway | 0.60 |
| APOE3 | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| Endothelial | activates | cell_type | 0.60 |
| ALZHEIMER | biomarker_for | gene | 0.60 |
| GABA | biomarker_for | gene | 0.60 |
| EPILEPSY | inhibits | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SLC17A7 | activates | gene | 0.60 |
| KDM6B | activates | gene | 0.60 |
| SLC17A6 | activates | gene | 0.60 |
| PSD95 | regulates | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| APOE4 | activates | gene | 0.60 |
| VEGF | activates | gene | 0.60 |
| VGLUT2 | associated_with | gene | 0.60 |
| APP | regulates | gene | 0.60 |
| MAPT | regulates | gene | 0.60 |
| BACE1 | regulates | gene | 0.60 |
| SYNAPTOPHYSIN | activates | gene | 0.60 |
| VGLUT2 | expressed_in | gene | 0.60 |
| SYNAPTOPHYSIN | expressed_in | gene | 0.60 |
| GFAP | activates | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| SLC17A7 | inhibits | gene | 0.60 |
| BDNF | inhibits | gene | 0.60 |
| MMP9 | expressed_in | gene | 0.60 |
| APOER2 | activates | gene | 0.60 |
| AMYLOID | regulates | gene | 0.60 |
| SYNAPSE | activates | gene | 0.60 |
| AXON | regulates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| MYELIN | regulates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| ALZHEIMER | biomarker_for | gene | 0.60 |
| GABA | biomarker_for | gene | 0.60 |
| AND | biomarker_for | gene | 0.60 |
| ALZHEIMER'S DISEASE | biomarker_for | gene | 0.60 |
| AMYLOID | biomarker_for | gene | 0.60 |
| EPILEPSY | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| INSULIN RESISTANCE | associated_with | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| PRESENILIN | regulates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| EPILEPSY | expressed_in | gene | 0.60 |
| COMPLEMENT | expressed_in | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| APOE3 | activates | gene | 0.60 |
| synaptic plasticity | activates | process | 0.60 |
| MAP | inhibits | gene | 0.60 |
| SLC17A7 | co_mentioned | gene | 0.55 |
| excitotoxicity | inhibits | process | 0.55 |
| SLC17A7 | regulates | gene | 0.55 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-10 | 0 hypotheses
neurodegeneration | 2026-04-10 | 0 hypotheses
neurodegeneration | 2026-04-10 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||